Insider Shareholders with Direct Ownership of Albireo Pharma, Inc. (ALBO)
This section provides a comprehensive overview of the insiders with direct ownership of Albireo Pharma, Inc. (ALBO). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
ALBIREO PHARMA, INC. Insider List
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
---|---|---|---|---|---|
Paul Streck
Chief Medical Officer |
118,966 | 0 | 118,966 $0 | 2 |
Jan 19, 2023
Added 31.62%
|
Patrick Taylor Horn
Chief Medical Officer |
5,500 | 474 | 12,355 $0 | 6 |
Oct 22, 2021
Reduced 0.76%
|
Craig C. Hopkinson
Director |
10,495 | 0 | 10,495 $0 | 1 |
Dec 01, 2022
Added 50.0%
|
Martha J. Carter
Chief Regulatory Officer |
71,300 | 5,450 | 3,654 $0 | 10 |
Mar 02, 2023
Reduced 50.01%
|
Simon N.R. Harford
CFO and Treasurer |
82,100 | 17,211 | 0 $0 | 19 |
Mar 02, 2023
Reduced 100.0%
|
Ronald Harold Wilfred Cooper
President and CEO |
255,673 | 48,350 | 0 $0 | 10 |
Mar 02, 2023
Reduced 100.0%
|
Jason Duncan
Chief Legal Officer and GC |
87,900 | 27,280 | 0 $0 | 27 |
Mar 02, 2023
Reduced 100.0%
|
Pamela Stephenson
Chief Commercial Officer |
82,100 | 28,954 | 0 $0 | 19 |
Mar 02, 2023
Reduced 100.0%
|
Michelle Graham
Chief Human Resources Officer |
59,100 | 8,150 | 0 $0 | 10 |
Mar 02, 2023
Reduced 100.0%
|
Jan Mattsson
Chief Scientific Officer |
121,430 | 71,694 | 0 $0 | 14 |
Mar 02, 2023
Reduced 100.0%
|
David Chiswell
Director |
0 | 56,278 | 0 $0 | 1 |
Mar 02, 2023
Reduced 100.0%
|